Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuraxial ondansetron vs pethidine vs dexmedetomidine for postoperative shivering after TURP
IRCT20250112064367N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postanesthetic shivering (PAS) comparing Ondansetron + bupivacaine, Pethidine + bupivacaine and Dexmedetomidine + bupivacaine (3 arms). Primary endpoints: Average shivering score in recovery and Average mean arterial pressure in recovery. Started Mar 2025; status: completed.
02
Drugs
ondansetronpethidinedexmedetomidinebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20250112064367N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250112064367N1.